sodium valproate news

All news on sodium valproate (also known as valproate, valproic acid sodium, valproic acid sodium salt, Depakene, Epilim, and divalproex sodium): plants, production capacities, investments and involved companies.

8 September 2026

Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026

24 abstracts at Psych Congress will report Phase 3 CAPLYTA data in bipolar mania, SPRAVATO analyses on anhedonia, seltorexant MDD+insomnia results, and LAI real‑world studies.
4 May 2026

Johnson & Johnson: CAPLYTA tops adjunctive MDD antipsychotics in network meta-analysis

Network meta-analysis of 10 trials found an adjunctive atypical antipsychotic superior on MADRS change, response, remission and CGI‑S, with no significant weight gain and favorable tolerability.

Who will be producing sodium valproate in the future?

Find out with chemXplore

Learn more